WHO Approves Johnson & Johnson's First Single-Shot Covid-19 Vaccine For Emergency Use

<p>A day after getting conditional approval by the European Union's drug regulating authority, Johnson &amp; Johnson's COVID-19 vaccine emergency use authorization by the World Health Organisation on Friday. The organisation allowed the one-shot dose to be used as part of the United Nation's international vaccine distribution effort.</p> <p>According to the reports, WHO chief Tedros Adhanom Ghebreyesus in an official statement said, "Every new, safe and effective tool against Covid-19 is another step closer to controlling the pandemic."</p> <p><strong>ALSO READ | <a href="https://ift.tt/3veAtXJ 'Single-Shot' Coronavirus Vaccine By Johnson &amp; Johnson Gets EU Approval</a></strong></p> <p>Johnson &amp; Johnson vaccine is currently recommended for those above 18 years of age. The vaccine is fourth to be endorsed for use in the EU after jabs from Pfizer-BioNTech, AstraZeneca-Oxford University and Moderna got approval.</p> <p>Johnson &amp; Johnson vaccination offers logistical advantages because of its single-dose and also doesn't require deep-freeze storage making it best suited for several hard-to-reach rural areas and unprivileged communities that have limited access to healthcare facilities.&nbsp;</p> <p>It is said to be the game changer in Coronavirus vaccination drive which is currently being conducted worldwide. The vaccine is first-of-its-kind as it requires only a single dose, unlike other vaccines that need two doses spaced weeks apart.</p> <p>However, the new vaccine has been on the radar of critiques due to lack of clarity about the jabs&rsquo; efficacy numbers. The trials showed the Johnson &amp; Johnson vaccine does not protect as well against a highly transmissible virus variant first identified in South Africa, which is spreading rapidly around the world.</p>

from coronavirus https://ift.tt/38DEuv0